In Henry et al. [3], LBD techniqueswere used to discover lecithin-cholesterol acyltransferase (LCAT) as a proposedtherapeutic target for cardiac arrest, a target that was later supported via in vivostudies. This evidence concerns the gene LCAT and cardiac arrest.